Trial Profile
Efficacy and safety of belatacept in adult kidney transplant recipients: A retrospective cohort study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Oct 2016
Price :
$35
*
At a glance
- Drugs Belatacept (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 07 Oct 2016 New trial record